Pios, Ailyn M.
HRN: 21-87-16 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/01/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
09/01/2022
09/08/2022
IV
300mg
Q6
Perianal Abscess
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes